Terms: = Liver cancer AND BCL2, Bcl-2, 596, ENSG00000171791
2472 results:
1. Molecular interactions between metformin and D-limonene inhibit proliferation and promote apoptosis in breast and liver cancer cells.
Salim EI; Alabasy MM; Nashar EME; Al-Zahrani NS; Alzahrani MA; Guo Z; Beltagy DM; Shahen M
BMC Complement Med Ther; 2024 May; 24(1):185. PubMed ID: 38711049
[TBL] [Abstract] [Full Text] [Related]
2. Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity.
Abo-Salem HM; El Souda SSM; Shafey HI; Zoheir KMA; Ahmed KM; Mahmoud K; Mahrous KF; Fawzy NM
Sci Rep; 2024 Apr; 14(1):9636. PubMed ID: 38671055
[TBL] [Abstract] [Full Text] [Related]
3. Epithelial-Mesenchymal Transformation Promotes the Progression of Hepatocellular Carcinoma through NF-κB/MMP9 Axis.
Li J; Cai Q; Wang Z; Wang L; Yang G; Zhang Z; Ge N; Hu S; Bai T
Discov Med; 2024 Apr; 36(183):666-677. PubMed ID: 38665016
[TBL] [Abstract] [Full Text] [Related]
4. Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein.
Wu T; Yang H; Li J; Fang H; Shi X; Li J; Feng L
PLoS One; 2024; 19(4):e0299920. PubMed ID: 38630658
[TBL] [Abstract] [Full Text] [Related]
5. [Bupleuri Radix-Paeoniae Radix Alba medicated plasma exerts effects on HepG2 hepatoma cells by regulating miR-1297/PTEN signaling axis].
Ding L; Wang RY; Zhang F; Wu MS; Chen B; Sun KW
Zhongguo Zhong Yao Za Zhi; 2024 Feb; 49(4):1073-1081. PubMed ID: 38621914
[TBL] [Abstract] [Full Text] [Related]
6. Protective Effects and Mechanisms of Esculetin against H
Luo Y; Chang T; Huang S; Xiang J; Tang S; Shen H
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611695
[TBL] [Abstract] [Full Text] [Related]
7. Probiotic-derived silver nanoparticles target mTOR/MMP-9/bcl-2/dependent AMPK activation for hepatic cancer treatment.
Elmetwalli A; Abdel-Monem MO; El-Far AH; Ghaith GS; Albalawi NAN; Hassan J; Ismail NF; El-Sewedy T; Alnamshan MM; ALaqeel NK; Al-Dhuayan IS; Hassan MG
Med Oncol; 2024 Apr; 41(5):106. PubMed ID: 38575697
[TBL] [Abstract] [Full Text] [Related]
8. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity.
Ge B; Yan K; Sang R; Wang W; Liu X; Yu M; Liu X; Qiu Q; Zhang X
Ecotoxicol Environ Saf; 2024 Apr; 275():116278. PubMed ID: 38564860
[TBL] [Abstract] [Full Text] [Related]
9. An integrated framework for prognosis prediction and drug response modeling in colorectal liver metastasis drug discovery.
Zhou X; Qian Y; Ling C; He Z; Shi P; Gao Y; Sui X
J Transl Med; 2024 Mar; 22(1):321. PubMed ID: 38555418
[TBL] [Abstract] [Full Text] [Related]
10. STIM1/SOX2 proteins are co-expressed in the tumor and microenvironmental stromal cells of pancreatic ductal adenocarcinoma and ampullary carcinoma.
Sweed D; Elhamed SMA; Aiad HAS; Ehsan NA; Hemida AS; Dawoud MM
World J Surg Oncol; 2024 Mar; 22(1):84. PubMed ID: 38532463
[TBL] [Abstract] [Full Text] [Related]
11. Investigation of apoptotic effects of Cucurbitacin D, I, and E mediated by Bax/Bcl-xL, caspase-3/9, and oxidative stress modulators in HepG2 cell line.
Üremiş MM; Türköz Y; Üremiş N
Drug Dev Res; 2024 Apr; 85(2):e22174. PubMed ID: 38494997
[TBL] [Abstract] [Full Text] [Related]
12. Evaluation of the cytotoxic activity of sorafenib-loaded camel milk casein nanoparticles against hepatocarcinoma cells.
Mittal A; Mahala N; Dhanawade NH; Dubey SK; Dubey US
Biotechnol J; 2024 Mar; 19(3):e2300449. PubMed ID: 38472095
[TBL] [Abstract] [Full Text] [Related]
13. Changes in chromatin accessibility and transcriptional landscape induced by HDAC inhibitors in TP53 mutated patient-derived colon cancer organoids.
Gagliano T; Kerschbamer E; Baccarani U; Minisini M; Di Giorgio E; Dalla E; Weichenberger CX; Cherchi V; Terrosu G; Brancolini C
Biomed Pharmacother; 2024 Apr; 173():116374. PubMed ID: 38447451
[TBL] [Abstract] [Full Text] [Related]
14. Carnosic Acid against Lung cancer: Induction of Autophagy and Activation of Sestrin-2/LKB1/AMPK Signalling.
O'Neill EJ; Sze NSK; MacPherson REK; Tsiani E
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396629
[TBL] [Abstract] [Full Text] [Related]
15. Exploring the cytotoxicity of dinuclear Ru(II)
Abirami A; Devan U; Ramesh R; Antony Joseph Velanganni A; Małecki JG
Dalton Trans; 2024 Mar; 53(11):5167-5179. PubMed ID: 38380977
[TBL] [Abstract] [Full Text] [Related]
16. Assessing the Potential Apoptotic Effects of Different Hydatid Cyst Fluids on Human Healthy Hepatocytes and Hepatocellular Carcinoma Cells.
Baysal İ; Örsten S; Cengiz G; Ünal E; Doğrul AB; Çiftçi T; Çiftçi SY; Akinci D; Akhan O
Acta Parasitol; 2024 Mar; 69(1):700-709. PubMed ID: 38372909
[TBL] [Abstract] [Full Text] [Related]
17. A codelivery system loaded with PDL1-siRNA and sorafenib enhances the therapeutic effect of sorafenib on hepatocellular carcinoma via TAT-poly-SS-lysine modified chitosan.
Chen Y; Jiang Z; Yan Z; Liu J; Lai Y; Li L; Lin X; Lin J
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130162. PubMed ID: 38365149
[TBL] [Abstract] [Full Text] [Related]
18. Synthesis and Characterization of Graphene Oxide/Polyethylene Glycol/Folic Acid/Brucine Nanocomposites and Their Anticancer Activity on HepG2 Cells.
Ibrahim IAA; Alzahrani AR; Alanazi IM; Shahzad N; Shahid I; Falemban AH; Nur Azlina MF; Arulselvan P
Int J Nanomedicine; 2024; 19():1109-1124. PubMed ID: 38344441
[TBL] [Abstract] [Full Text] [Related]
19. Identification of Erzhu Jiedu Recipe and its molecular mechanism underlying inhibited human hepatoma cells by UHPLC-Q-Exactive Orbitrap HRMS and network pharmacology.
Wang F; Mai J; Wang H; Xu Y; Zhou X; Xie Z; Yu B; Liu P; Liu W; Cheng Y
J Ethnopharmacol; 2024 May; 325():117893. PubMed ID: 38336184
[TBL] [Abstract] [Full Text] [Related]
20. Green-Synthesized Silver and Selenium Nanoparticles Using Berberine: A Comparative Assessment of In Vitro Anticancer Potential on Human Hepatocellular Carcinoma Cell Line (HepG2).
Khaled AM; Othman MS; Obeidat ST; Aleid GM; Aboelnaga SM; Fehaid A; Hathout HMR; Bakkar AA; Moneim AEA; El-Garawani IM; Morsi DS
Cells; 2024 Feb; 13(3):. PubMed ID: 38334679
[TBL] [Abstract] [Full Text] [Related]
[Next]
